Moyamoya Disease disease mechanism in adults
Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing and eventual occlusion of the terminal portions of the internal carotid arteries and their main branches. While it is often diagnosed in children, it also significantly affects adults, presenting unique challenges in understanding its underlying mechanisms. The disease’s name, derived from a Japanese term meaning “puff of smoke,” reflects the appearance of abnormal collateral vessels formed as a compensatory response to arterial blockage.
In adults, the pathophysiology of moyamoya disease involves a complex interplay of genetic, vascular, and cellular factors. The primary event is the progressive stenosis or occlusion of the distal internal carotid arteries and the proximal segments of the anterior and middle cerebral arteries. This narrowing reduces blood flow to the brain regions these arteries supply, leading to ischemia and increasing the risk of strokes. As the primary arteries become constricted, the brain endeavors to maintain adequate perfusion through the development of collateral circulation—networks of tiny blood vessels that bypass the blocked segments.
These collateral vessels form via a process known as angiogenesis, stimulated by ischemic conditions in the brain tissue. The newly formed vessels, however, are often fragile, abnormal, and prone to rupture or thrombosis, which can lead to hemorrhagic strokes—a common presentation in adult moyamoya patients. The abnormal vasculature resembles a “puff of smoke” on angiographic imaging, which is characteristic of the disease and helps in diagnosis.
At the cellular level, the disease process involves abnormalities in the internal elastic lamina and smooth muscle cells within the arterial walls. Pathological studies have revealed intimal thickening due to proliferation of smooth muscle cells and deposition of extracellular matrix components. This thickening narrows the lumen of the arteries, compromising blood flow. Concurrently, there is evidence of endothelial dysfunction and inflammation, contributing to progressive vessel stenosis.
Genetics also play a significant role in the disease mechanism. Although the exact genetic factors are not fully understood, familial cases suggest a hereditary component, with certain gene mutations identified in some populations. These genetic predispositions may influence the structural integrity of cerebral vessels or the regulation of angiogenic processes.
In adults, the clinical manifestations of moyamoya are often diverse, reflecting both ischemic and hemorrhagic phenomena. Ischemic strokes and transient ischemic attacks (TIAs) are common, resulting from insufficient blood supply. Hemorrhagic strokes occur due to rupture of fragile collateral vessels. The variability in presentation underscores the importance of understanding the underlying mechanisms, as they guide therapeutic strategies.
Overall, adult moyamoya disease involves progressive arterial stenosis driven by cellular proliferation, extracellular matrix changes, and abnormal angiogenesis, compounded by genetic factors. Recognizing these mechanisms is crucial for diagnosis, management, and ultimately improving outcomes for affected individuals.